- PMID: 32612530
- PMCID: PMC7308536
- DOI: 10.3389/fphar.2020.00893
Abstract
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening complication that can ensue following Staphylococcus aureus infection. The enterotoxin produced by these bacteria (SEB) acts as a superantigen thereby activating a large proportion of T cells leading to cytokine storm and severe lung injury. Δ9Tetrahydrocannabinol (THC), a psychoactive ingredient found in Cannabis sativa, has been shown to act as a potent anti-inflammatory agent. In the current study, we investigated the effect of THC treatment on SEB-induced ARDS in mice. While exposure to SEB resulted in acute mortality, treatment with THC led to 100% survival of mice. THC treatment significantly suppressed the inflammatory cytokines, IFN-γ and TNF-α. Additionally, THC elevated the induction of regulatory T cells (Tregs) and their associated cytokines, IL-10 and TGF-β. Moreover, THC caused induction of Myeloid-Derived Suppressor Cells (MDSCs). THC acted through CB2 receptor as pharmacological inhibitor of CB2 receptors blocked the anti-inflammatory effects. THC-treated mice showed significant alterations in the expression of miRNA (miRs) in the lung-infiltrated mononuclear cells (MNCs). Specifically, THC caused downregulation of let7a-5p which targeted SOCS1 and downregulation of miR-34-5p which caused increased expression of FoxP3, NOS1, and CSF1R. Together, these data suggested that THC-mediated alterations in miR expression in the lungs may play a critical role in the induction of immunosuppressive Tregs and MDSCs as well as suppression of cytokine storm leading to attenuation of SEB-mediated lung injury.
Keywords: CB2 receptor, Myeloid-Derived Suppressor Cells, Staphylococcal enterotoxin B (SEB), Tregs, acute respiratory distress syndrome, miR-34a, microRNA, Δ9-Tetrahydrocannabinol (THC)
Copyright © 2020 Mohammed, Alghetaa, Sultan, Singh, Nagarkatti and Nagarkatti.
References
-
- Alghetaa H., Mohammed A., Sultan M., Busbee P., Murphy A., Chatterjee S., et al. (2018). Resveratrol protects mice against SEB-induced acute lung injury and mortality by miR-193a modulation that targets TGF-beta signalling. J. Cell Mol. Med. 22 (5), 2644–2655. 10.1111/jcmm.13542 – DOI – PMC – PubMed
- Al-Ghezi Z. Z., Busbee P. B., Alghetaa H., Nagarkatti P. S., Nagarkatti M. (2019. a). Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain Behav. Immun. 82, 25–35. 10.1016/j.bbi.2019.07.028 – DOI – PMC – PubMed
- Al-Ghezi Z. Z., Miranda K., Nagarkatti M., Nagarkatti P. S. (2019. b). Combination of Cannabinoids, Delta9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Front. Immunol. 10, 1921. 10.3389/fimmu.2019.01921 – DOI – PMC –PubMed
- Alharris E., Alghetaa H., Seth R., Chatterjee S., Singh N. P., Nagarkatti M., et al. (2018). Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice. Front. Immunol. 9, 2992. 10.3389/fimmu.2018.02992 – DOI – PMC – PubMed







